‘Off-the-Shelf’ Curative Cell Therapies
Cell BioEngines has raised $12.5M in total funding. The most recent round was Seed. The last funding was announced in November 2025.
Cell BioEngines's investors include SOSV, SOSV SF & NY (Fka IndieBio), New York Ventures, Prevail Partners, Harvard Innovation Labs.
Cell BioEngines is headquartered in Wilmington, United States.
‘Off-the-Shelf’ Curative Cell Therapies
Cell BioEngines is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cell BioEngines — Funding & Investors." VCBacked, November 1, 2025, https://www.vcbacked.co/company/cell-bioengines. Accessed August 13, 2026.
VCBacked. (2025). Cell BioEngines — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/cell-bioengines
{{cite web |title=Cell BioEngines — Funding & Investors |url=https://www.vcbacked.co/company/cell-bioengines |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated